# Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients

> **NCT03903419** · NA · UNKNOWN · sponsor: **Centre Leon Berard** · enrollment: 16 (estimated)

## Conditions studied

- Glioblastomas

## Interventions

- **DIAGNOSTIC_TEST:** Feasibility study for the realization of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT for identification of early recurrence in patients treated with radiotherapy for glioblastoma.

## Key facts

- **NCT ID:** NCT03903419
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-16
- **Primary completion:** 2021-08-16
- **Final completion:** 2021-08-16
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2020-10-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03903419

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03903419, "Feasibility Study of 68Ga-PSMA PET-CT and 18F-FDOPA PET-CT in Glioblastoma's Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03903419. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*